{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:24:17Z","timestamp":1778642657544,"version":"3.51.4"},"reference-count":43,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004441","name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine prevalent <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> genotypes and describe treatment outcome and bacteriology conversion in <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Review of laboratory records of 173 <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> patients from all over Rwanda who initiated treatment under programmatic management of <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">PMDT<\/jats:styled-content>) between 2014 and 2015. Fifty available archived isolates were genotyped by mycobacterial interspersed repetitive units \u2013 variable number of tandem repeats (<jats:styled-content style=\"fixed-case\">MIRU<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">VNTR<\/jats:styled-content>) genotyping.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Of the 170 patients whose outcome was known, 114 (66.3%) were cured and 36 (21%) completed the treatment, giving a successful outcome (cured and completed) of 150 (87.3%) patients. Of 20 <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> patients with unfavourable treatment outcome, 18 died, one failed and one defaulted\/stopped treatment. Of the 18 patients who died, 11 (61%) were <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010coinfected. The treatment outcome was successful for 93.9% among <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> negative and 81.8% among <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010coinfected patients (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.02). Sputum smear conversion occurred in 3, 46, 57 and 78 patients before 2, 3, 4 and 6\u00a0months, respectively, with median time of sputum smear and culture conversion at 3\u00a0months. The 44 <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> isolates with <jats:styled-content style=\"fixed-case\">MIRU<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">VNTR<\/jats:styled-content> result, showed high genetic diversity with low clustering rate (9.09%) and Uganda <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content> being the most prevalent sub\u2010family lineage detected in 68.2% of isolates. Beijing family was the least common genotype detected (2.3%, 1 isolate).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The high success rates for <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> treatment achieved in Rwanda were comparable to outcomes observed in resource\u2010rich settings with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> being an independent risk factor for poor treatment outcome. High genetic diversity and low clustering rate reported here suggest that reactivation of previous disease plays an important role in the transmission of <jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> in Rwanda.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tmi.13245","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T01:48:20Z","timestamp":1557280100000},"page":"879-887","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Highly successful treatment outcome of multidrug\u2010resistant and genetic diversity of multidrug\u2010resistant <i>Mycobacterium tuberculosis<\/i> strains in Rwanda"],"prefix":"10.1111","volume":"24","author":[{"given":"Claude Mambo","family":"Muvunyi","sequence":"first","affiliation":[{"name":"Department of Clinical Biology School of Medicine and Pharmacy University of Rwanda Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude Semuto","family":"Ngabonziza","sequence":"additional","affiliation":[{"name":"National Reference Laboratory Division Rwanda Biomedical Centre Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocent","family":"Uwimana","sequence":"additional","affiliation":[{"name":"National Reference Laboratory Division Rwanda Biomedical Centre Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean De Dieu","family":"Harelimana","sequence":"additional","affiliation":[{"name":"Department of Biomedical Laboratory Science School of Health Science University of Rwanda Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Mucyo","sequence":"additional","affiliation":[{"name":"Tuberculosis and Other Respiratory Diseases Division Rwanda Biomedical Centre Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osee Rurambya","family":"Sebatunzi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine School of Medicine and Pharmacy University of Rwanda Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry Zawadi","family":"Muvunyi","sequence":"additional","affiliation":[{"name":"Department of Pathology Rwanda Military Hospital Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Seruyange","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine School of Medicine and Pharmacy University of Rwanda Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Masaisa","sequence":"additional","affiliation":[{"name":"Department of Clinical Biology School of Medicine and Pharmacy University of Rwanda Kigali Rwanda"},{"name":"Department of Internal Medicine School of Medicine and Pharmacy University of Rwanda Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Baptiste","family":"Mazarati","sequence":"additional","affiliation":[{"name":"National Reference Laboratory Division Rwanda Biomedical Centre Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Gasana","sequence":"additional","affiliation":[{"name":"Tuberculosis and Other Respiratory Diseases Division Rwanda Biomedical Centre Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"1","volume-title":"Global Tuberculosis Control: Surveillance, Planning, Financing","author":"World Health Organization","year":"2008"},{"key":"e_1_2_7_3_1","unstructured":"World Health Organization.Global Tuberculosis Report 2017.WHO:Geneva 2017. (Available from:http:\/\/www.who.int\/tb\/publications\/global_report\/en\/) [12 April 2018]"},{"key":"e_1_2_7_4_1","unstructured":"UmubyeyiAN VandebrielG GasanaM RigoutsL.Tuberculosis patients in Rwanda Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda;2015(March 2007)."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00061-05"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.3103\/S0891416811010034"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.35.4.907-914.1997"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-148-2-519"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/591974"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb01558.x"},{"key":"e_1_2_7_11_1","first-page":"153","article-title":"Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains","volume":"188","author":"Kremer K","year":"2005","journal-title":"J Clin Microbiol"},{"key":"e_1_2_7_12_1","first-page":"860","article-title":"Molecular investigation of recurrent tuberculosis in patients from Rwanda","volume":"11","author":"Umubyeyi AN","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6890-12-20"},{"key":"e_1_2_7_14_1","unstructured":"PhilipS.Multilocus Variable Number Tandem Repeat Genotyping of Mycobacterium tuberculosis. Technical Guide. INSERM U629 Institut de Biologie\/Institut Pasteur de Lille France;2005."},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01392-06"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02274-10"},{"key":"e_1_2_7_17_1","unstructured":"World Implementing the End TB Strategy: the essential (WHO\/HTM\/TB\/2015.31).World Health Organization:Geneva;2015. (Available from:http:\/\/www.who.int\/tb\/publications\/2015\/end_tb_essential.pdf.)"},{"key":"e_1_2_7_18_1","first-page":"1","volume-title":"The Global Plan to End TB 2016\u20132020","author":"Pl Stop TB Partnership","year":"2016"},{"key":"e_1_2_7_19_1","first-page":"758","article-title":"Multidrug\u2010resistant tuberculosis: long\u2010term treatment outcome in the Netherlands","volume":"4","author":"Geerligs WA","year":"2000","journal-title":"Int J Tuberc lung Dis"},{"key":"e_1_2_7_20_1","first-page":"406","article-title":"Highly successful treatment outcome of multidrug\u2010resistant tuberculosis in the Netherlands, 2000\u20132009","volume":"2015","author":"Altena R","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-016-0214-x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23344-z"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0498"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02308-2016"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0834"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20172122"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcdt.2015.12.018"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006914"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2015.11.011"},{"key":"e_1_2_7_30_1","volume-title":"Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India","author":"Central TB division","year":"2012"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142873"},{"key":"e_1_2_7_32_1","first-page":"1","article-title":"Risk factors for poor multidrugresistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine","volume":"17","author":"Aibana O","year":"2017","journal-title":"Bio Med Cent Infect Dis"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-6-23"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.10.3563-3571.2001"},{"key":"e_1_2_7_35_1","first-page":"306","article-title":"Genetic diversity of Mycobacterium tuberculosis in Mbarara, South Western Uganda","volume":"10","author":"Bazira J","year":"2011","journal-title":"Afr Health Sci"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.05.020"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.10.4536-4544.2004"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135695"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.3844\/ajidsp.2005.5.11"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030331"},{"key":"e_1_2_7_41_1","first-page":"101","article-title":"Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South\u2010Western Uganda","volume":"8","author":"Bazira J","year":"2011","journal-title":"BMC Infect Dis"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-7-51"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-6-76"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.140102797"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftmi.13245","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tmi.13245","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tmi.13245","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tmi.13245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T15:24:27Z","timestamp":1694273067000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tmi.13245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1111\/tmi.13245"],"URL":"https:\/\/doi.org\/10.1111\/tmi.13245","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"2019-06-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}